Hughes D - Search Results

1

Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy.

Deegan PB, Pavlova E, Tindall J, Stein PE, Bearcroft P, Mehta A, Hughes D, Wraith JE, Cox TM. Deegan PB, et al. Among authors: hughes d. Medicine (Baltimore). 2011 Jan;90(1):52-60. doi: 10.1097/MD.0b013e3182057be4. Medicine (Baltimore). 2011. PMID: 21200186 Free article.

2

Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease.

Shah JS, Hughes DA, Sachdev B, Tome M, Ward D, Lee P, Mehta AB, Elliott PM. Shah JS, et al. Among authors: hughes da. Am J Cardiol. 2005 Sep 15;96(6):842-6. doi: 10.1016/j.amjcard.2005.05.033. Am J Cardiol. 2005. PMID: 16169374

3

The role of heparin in alleviating complement-mediated acute intravascular haemolysis.

Mannari D, Liu C, Hughes D, Mehta A. Mannari D, et al. Among authors: hughes d. Acta Haematol. 2008;119(3):166-8. doi: 10.1159/000134221. Epub 2008 May 21. Acta Haematol. 2008. PMID: 18493118

4

The binary endocardial appearance is a poor discriminator of Anderson-Fabry disease from familial hypertrophic cardiomyopathy.

Kounas S, Demetrescu C, Pantazis AA, Keren A, Lee PJ, Hughes D, Mehta A, Elliott PM. Kounas S, et al. Among authors: hughes d. J Am Coll Cardiol. 2008 May 27;51(21):2058-61. doi: 10.1016/j.jacc.2008.02.046. J Am Coll Cardiol. 2008. PMID: 18498962 Free article.

5

Guidelines for the restart of imiglucerase in patients with Gaucher disease: recommendations from the European Working Group on Gaucher disease.

Hollak CE, Aerts JM, Belmatoug N, Bembi B, Bodamer O, Cappellini D, Collin-Histed T, Cox TM, Deegan P, Giraldo P, Hughes D, Lukina E, Manuel J, Michelakakis H, Di Rocco M, Vellodi A, Zimran A. Hollak CE, et al. Among authors: hughes d. Blood Cells Mol Dis. 2010 Mar-Apr;44(2):86-7. doi: 10.1016/j.bcmd.2009.12.002. Blood Cells Mol Dis. 2010. PMID: 20022271 No abstract available.

6

Expert opinion on temporary treatment recommendations for Fabry disease during the shortage of enzyme replacement therapy (ERT).

Linthorst GE, Germain DP, Hollak CE, Hughes D, Rolfs A, Wanner C, Mehta A; European Medicines Agency. Linthorst GE, et al. Among authors: hughes d. Mol Genet Metab. 2011 Jan;102(1):99-102. doi: 10.1016/j.ymgme.2010.11.155. Epub 2010 Nov 30. Mol Genet Metab. 2011. PMID: 21123099

7

Response of women with Fabry disease to enzyme replacement therapy: comparison with men, using data from FOS--the Fabry Outcome Survey.

Hughes DA, Barba Romero MÁ, Hollak CE, Giugliani R, Deegan PB. Hughes DA, et al. Mol Genet Metab. 2011 Jul;103(3):207-14. doi: 10.1016/j.ymgme.2011.03.022. Epub 2011 Mar 31. Mol Genet Metab. 2011. PMID: 21543245 Clinical Trial.

8

Functional analysis of variant lysosomal acid glycosidases of Anderson-Fabry and Pompe disease in a human embryonic kidney epithelial cell line (HEK 293 T).

Ebrahim HY, Baker RJ, Mehta AB, Hughes DA. Ebrahim HY, et al. J Inherit Metab Dis. 2012 Mar;35(2):325-34. doi: 10.1007/s10545-011-9395-4. Epub 2011 Oct 5. J Inherit Metab Dis. 2012. PMID: 21972175

9

Gaucher disease: outcome following total hip replacements and effect of enzyme replacement therapy in a cohort of UK patients.

Donaldson J, Khan WS, Tailor H, Hughes DA, Mehta AB, Maruthainar N. Donaldson J, et al. Hip Int. 2011 Nov-Dec;21(6):665-71. doi: 10.5301/HIP.2011.8826. Hip Int. 2011. PMID: 22101622

10

Gaucher disease: hematologic and oncologic implications.

Hughes D. Hughes D. Clin Adv Hematol Oncol. 2011 Oct;9(10):771-2. Clin Adv Hematol Oncol. 2011. PMID: 22252578 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,006 results

Search Page

Filters